Biotechnology
| Mon 10 Aug 2026
Alexandria, Aug. 11 -- U.S. Patent and Trademark Office has released Zelluna Immunotherapy AS patent application for Anti-MAGE-A4 T Cell Receptors. This invention was developed by Robinson Ross, Boieri Margherita, Cardose Inês, Dixon Thomas, Løset Geir Age, Pollmann Syivie, Ouaray Zahra, Hurst Jacob, Frigstad Terje, Teng Miche..